New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Despite the staggering impact of obesity on the Black community, columnist Justice B. Hill argues that the issue has been ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

Medicare announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy ...

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Doctors worldwide should adopt a more comprehensive approach to diagnosing obesity, incorporating broader criteria and ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...